Phage-specific antibodies: are they a hurdle for the success of phage therapy?
2024

Phage-Specific Antibodies and Their Impact on Phage Therapy

publication Evidence: moderate

Author Information

Author(s): Santini Joanne M, Washizaki Ayaka, Sakiyama Arata, Ando Hiroki

Primary Institution: Gifu University

Hypothesis

Do phage-specific antibodies influence the outcomes of phage therapy?

Conclusion

Phage-specific antibodies can lead to rapid clearance of phages from the body, potentially affecting the efficacy of phage therapy.

Supporting Evidence

  • Phage-specific antibodies can promote phage uptake by macrophages.
  • Neutralizing antibodies can diminish the antibacterial activity of phages.
  • Clinical trials show inconsistent results regarding the influence of phage-specific antibodies on treatment outcomes.

Takeaway

When we use phages to fight bacteria, our body can make antibodies against them, which might make the treatment less effective.

Methodology

This review summarizes various studies on phage-specific antibodies and their effects on phage therapy outcomes.

Limitations

The relationship between phage-specific antibodies and clinical outcomes remains unclear and controversial.

Digital Object Identifier (DOI)

10.1042/EBC20240024

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication